FATE THERAPEUTICS INC
•1434316
Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing off-the-shelf cellular immunotherapies. They utilize induced pluripotent stem cells (iPSCs) to create readily available cell therapies. Their focus is on treating autoimmune diseases and cancer with engineered cell products.
85
Meget PåliteligOffisielt Register
AI Kvalitetsanalyse
Tillitsscore Detaljer
Register Verifisert35/35
Kvalitetsscore50/60
Nyhetsanalyse0/5
Snarveier
Nettside Høydepunkter
Overview - Fate Therapeutics
To create better cell therapies, we have pioneered a therapeutic approach that we generally refer to as cell programming: we create and engineer human induced p
Join Our Team - Fate Therapeutics
Join Fate Therapeutics and become a vital member of our team working to develop groundbreaking cellular immunotherapies for patients suffering from cancer and a
iPSC Platform - Fate Therapeutics
iPSC Platform A Pluripotent Cell Platform for Enabling an Off-the-Shelf Engineered Immunotherapy Revolution Induced pluripotent stem cell (iPSC) technology has
Investors | Fate Therapeutics, Inc.
The Investor Relations website contains information about Fate Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.
Home - Fate Therapeutics
Sist oppdatert: 12/31/2025
🌟 Lignende Pålitelige Bedrifter
GTP BIOWAYS CDMO
G
76/100 · Pålitelig
OLON France er en erfaren CDMO som betjener biofarmasøytisk industri. De tilbyr et bredt spekter av tjenester, inkludert prosessutvikling, GMP-produksjon og analytisk utvikling for biologiske legemidler. Deres ekspertise omfatter produksjon i pattedyrceller, mikrobielle systemer og biokonjugater, noe som posisjonerer dem som en allsidig partner for legemiddelutvikling.
ACTISUD 18 RUE JEAN PERRIN 31100 TOULOUSE, Frankrike